Paola Signorelli Selected Research

Paola Signorelli Research Topics

Disease

12	Inflammation (Inflammations) 01/2022 - 01/2014
7	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 01/2014
7	Infections 01/2021 - 01/2014
6	Neoplasms (Cancer) 10/2015 - 08/2005
4	Pneumonia (Pneumonitis) 01/2020 - 01/2015
4	Chronic Obstructive Pulmonary Disease (COPD) 08/2017 - 01/2015
3	Parkinson Disease (Parkinson's Disease) 06/2021 - 07/2020
3	Proteostasis Deficiencies 06/2021 - 01/2020
3	Breast Neoplasms (Breast Cancer) 11/2010 - 12/2003
2	Reperfusion Injury 01/2019 - 03/2016
2	Ischemia 01/2019 - 03/2016
2	Necrosis 01/2019 - 03/2016
2	Carcinogenesis 10/2015 - 08/2005
2	Stomach Neoplasms (Stomach Cancer) 10/2015 - 09/2009
1	Chronic Renal Insufficiency 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2020
1	Myocardial Infarction 01/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019
1	Infarction (Infarctions) 01/2019
1	Emphysema 08/2017
1	Retinal Degeneration 07/2017
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 07/2017
1	Mycoses (Diseases, Fungus) 06/2016
1	Myocardial Reperfusion Injury 03/2016
1	Coronary Occlusion 03/2016
1	Aspergillosis 10/2015
1	Acute Lung Injury 01/2015
1	Colonic Neoplasms (Colon Cancer) 02/2014
1	Communicable Diseases (Infectious Diseases) 01/2014
1	Carcinoma (Carcinomatosis) 12/2012
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2002

Drug/Important Bio-Agent (IBA)

15	SphingolipidsIBA 01/2021 - 01/2005
11	CeramidesIBA 06/2021 - 12/2003
9	LipidsIBA 06/2021 - 01/2014
8	thermozymocidin (myriocin)IBA 01/2021 - 01/2014
4	ResveratrolIBA 10/2015 - 12/2003
3	EnzymesIBA 01/2021 - 08/2005
3	AntioxidantsIBA 01/2020 - 01/2015
2	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2020
2	CholesterolIBA 01/2021 - 01/2020
2	Phenylalanine (L-Phenylalanine)FDA Link 01/2020 - 01/2020
2	dihydroceramideIBA 12/2012 - 09/2009
1	CurcuminIBA 01/2022
1	SynucleinsIBA 06/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	SphingomyelinsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 12/2020
1	Cholesterol Esters (Cholesteryl Esters)IBA 12/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2020
1	Ether (Diethyl Ether)IBA 12/2020
1	SugarsIBA 07/2020
1	Therapeutic UsesIBA 01/2020
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2020
1	Histones (Histone)IBA 01/2020
1	We 201IBA 08/2017
1	Chloride Channels (Chloride Channel)IBA 08/2017
1	SmokeIBA 07/2017
1	CytokinesIBA 07/2017
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 07/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	Serine (L-Serine)FDA Link 01/2016
1	TransferasesIBA 01/2016
1	Surface-Active Agents (Surfactants)IBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 02/2014
1	Etoposide (VP 16)FDA LinkGeneric 12/2012
1	dihydroceramide desaturaseIBA 12/2012
1	DNA (Deoxyribonucleic Acid)IBA 11/2010
1	Biological ProductsIBA 08/2005
1	Nitric Oxide Synthase (NO Synthase)IBA 08/2005
1	Mitogen-Activated Protein KinasesIBA 08/2005
1	Phosphotransferases (Kinase)IBA 08/2005
1	Tyrosine (L-Tyrosine)FDA Link 08/2005
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 08/2005
1	PolyphenolsIBA 08/2005
1	Caspase 9IBA 10/2002
1	Cytochromes c (Cytochrome c)IBA 10/2002

Therapy/Procedure

3	Therapeutics 01/2020 - 10/2015
2	Drug Therapy (Chemotherapy) 10/2015 - 01/2015
1	Thrombolytic Therapy 01/2019
1	Percutaneous Coronary Intervention 01/2019
1	Radiotherapy 10/2015
1	Canes (Cane) 05/2008